XK and influenza: Punicalagin, an ellagitannin with strong anti-influenza activity, has demonstrated its primary mechanism of action by acting on the NA-mediated viral release, in addition to its inhibitory activity on the replication of influenza A and B viruses, including oseltamivir-resistant virus (NA/H274Y) (Li et al., 2021).